Sana Biotechnology, Inc.
SANA· Nasdaq
Sana Biotechnology, Inc.
- Last sale
- Oct 1, 2026 · -0.69%
- Market cap
- $865.15M
- 299.36M shares
- Filings
- 388
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $131,980,000 | reported | |
| FY 2024 | 2024-12-31 | $215,673,000 revised | reported | |
| FY 2023 | 2023-12-31 | $261,809,000 revised | reported | |
| FY 2022 | 2022-12-31 | $285,885,000 | reported | |
| FY 2021 | 2021-12-31 | $248,626,000 | reported | |
| FY 2020 | 2020-12-31 | $132,944,000 | reported | |
| FY 2019 | 2019-12-31 | $99,591,000 | reported |
Sana Biotechnology, Inc. · CIK 1770121 · Engraved from SEC EDGAR
